Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., . . . Van Hemelrijck, M. (2020). Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study. Front Oncol.
Chicago-stil citatSollie, Sam, et al. "Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study." Front Oncol 2020.
MLA-referensSollie, Sam, et al. "Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study." Front Oncol 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.